z-logo
open-access-imgOpen Access
Interleukin-1 receptors and receptor antagonist in haemodialysis
Author(s) -
D Donati,
Dimitrios Degiannis,
Emanuele Mazzola,
L Gastaldi,
Jana Rašková,
K Raska,
Giovanni Camussi
Publication year - 1997
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/12.1.111
Subject(s) - medicine , receptor , receptor antagonist , interleukin 1 receptor antagonist , hemodialysis , peripheral blood mononuclear cell , endocrinology , end stage renal disease , population , antagonist , interleukin , immunology , cytokine , biology , in vitro , biochemistry , environmental health
Biological activity of interleukin-1 (IL-1) depends on the number and type of IL-1 receptors on target cells and on the amounts of its naturally occurring inhibitor, the IL-1 receptor antagonist (IL-1ra).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom